Evidence map›Paper›PMID 41602855›Full record

ArticleFrontiers in neural circuits2025

Tunable dual-AAV sparse labeling of PV

Lingbo Zhou, Gao Tan, Yu Li, Man Yuan, Sen Jin, Wenhui Zhang, Qitian Wang, Yin Shen

Abstract read
In one paragraph

Article in Frontiers in neural circuits, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lingbo Zhou *Eye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
Gao Tan *Eye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
Yu Li *Eye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
Man YuanEye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
Sen JinZhongmou Therapeutics Co., Ltd., Wuhan, Hubei, China.
Wenhui ZhangEye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
Qitian WangZhongmou Therapeutics Co., Ltd., Wuhan, Hubei, China.
Yin ShenEye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sparse and bright labeling of retinal ganglion cell (RGC) is essential for correlating single-cell morphology with brain-wide visual circuitry. This study aimed to develop a cell-type-specific, sparse labeling strategy for parvalbumin-expressing RGCs (PV Methods: A cell-type-specific dual AAV system was employed, co-packaging a Cre-dependent Flpo plasmid and an Flpo-dependent enhanced yellow fluorescent protein (EYFP) plasmid. Key parameters-including the mixing ratio of core plasmids (ranging from 1/100 to 1/1000), gene copy number of Flpo and EYFP (single versus double), and AAV serotype (AAV2.2 versus engineered AAV2.NN)-were systematically optimized. Transduction efficiency and labeling sparsity under each condition were compared. Whole-retina-to-brain imaging was performed using fMOST on samples injected with the optimal condition (AAV2.2-double-1/1000), enabling the reconstruction of complete axonal trajectories of individual PV Results: The sparsity and signal intensity of labeled RGCs varied significantly with the core plasmid ratio, AAV serotype, and gene copy number. The engineered AAV2.NN serotype increased transduction efficiency and labeling density under equivalent conditions, which facilitated the morphological subclassification of PV Discussion: This viral labeling platform effectively resolves the classical trade-off between sparsity and signal intensity, providing a robust methodology for whole-brain mapping of individual RGC projections. The approach establishes a practical foundation for future mechanistic and therapeutic studies investigating subtype-selective vulnerability in RGCs.

Indexed as

DependovirusParvalbuminsRetinal Ganglion CellsTomography, OpticalVisual PathwaysAnimalsLuminescent ProteinsMiceMice, TransgenicLuminescent ProteinsParvalbuminsAAVfMOSTPV+ RGCsingle cell reconstructionsparse labeling

Identifiers

PMID41602855
PMCPMC12833038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.